Thu, Mar 28, 2024
A A A
Welcome Guest
Free Trial RSS pod
Get FREE trial access to our award winning publications
Alternative Market Briefing

Europe’s quantitative easing pushes hedge funds up 2.25% in February

Wednesday, March 18, 2015

Komfie Manalo, Opalesque Asia:

The European Central Bank’s extension of aid to Greece and its new EUR 1.1tln stimulus package rallied European equity markets, that helped pushed hedge funds to gain 2.2% last month, said data provider BarclayHedge. It added that the quantitative easing also calmed down deflation fears on rising prices for oil and other commodities.

The Barclay Hedge Fund Index was up 2.14% year-to-date. "Risk factors were largely out of the limelight in February," says Sol Waksman, founder and president of BarclayHedge.

All but one of Barclay’s 18 hedge fund indices had gains in February. The Healthcare & Biotechnology Index jumped 4.49%, equity long bias was up 4.02%, the Event Driven Index gained 3.57%, Pacific Rim Equities rose 2.81%, Distressed Securities added 2.18%, and European equities were up 2.09%.

The only losing hedge fund strategy in February was the Equity Short Bias Index, which dropped 3.70%. Equity short bias is down 3.70% year-to-date.

After two months in 2015, healthcare & biotechnology leads all hedge fund indices with a 6.81% gain. European equities are up 2.81%, equity long bias has gained 2.74%, global macro is up 2.71%, and the Event Driven Index has gained 2.49%.

The Barclay Fund of Funds Index gained 1.74% in February, and is up 2.02% for the year.......................

To view our full article Click here

Previous Opalesque Exclusives                                  
Previous Other Voices                                               
Access Alternative Market Briefing

 



  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. KKR raises $6.4bn for the largest pan-Asia infrastructure fund[more]

    Laxman Pai, Opalesque Asia: The New York-based global investment firm KKR has raised a record $6.4bn for its second Asia-focused infrastructure fund, underlining investors' continued appetite for private markets. According to a media release from the alternative assets manager, the figure top

  2. Bucking the trend, top hedge fund makes plans for a second SPAC[more]

    From Institutional Investor: SPACs aren't dead. At least not to the folks at Cormorant Asset Management. The life sciences firm, whose hedge fund topped its peers in 2023, is confident it will match the success of its first blank-check company. Last week, the life sciences and biopharma speciali

  3. Benefit Street Partners closes fifth fund on $4.7 billion[more]

    Bailey McCann, Opalesque New York: Benefit Street Partners has closed its fifth flagship direct lending vehicle, BSP Debt Fund V, with $4.7 billion of investable capital across the strategy. Benefit Street invests primarily in privately originated, floating rate, senior secured loans. The fun

  4. 4 hedge fund themes that are working in 2024[more]

    From The Street: A poor earnings report from Tesla (TSLA) has not hurt the indexes on Thursday. The decline in Tesla stock, which is losing its position in the Magnificent Seven pantheon, is more than offset by strong earnings from IBM (IBM) and ServiceNow (NOW) . In addition, the much higher-t

  5. Opalesque Exclusive: A global macro fund eyes opportunities in bonds[more]

    Bailey McCann, Opalesque New York for New Managers: Munich-based ThirdYear Capital rebounded in 2023, following a tough year for global macro. The firm's flagship ART Global Macro strategy finished the year up 1